← Directory

CLAiR

Toku Eyes

CE markedcardiovascular riskoculomics

Reads a standard retinal photo to estimate cardiovascular disease risk during a routine eye exam. Toku also sells BioAge and has MyKidneyAI in development.

US: FDA Breakthrough designation only, not clearance.

Company
Toku Eyes
Category
Other
Reads
Color retinal images from existing fundus cameras
Built for
Optometrists and ophthalmologists, cardiovascular risk programs
Billing
Check vendor
Regulatory
CE and UKCA marks (Feb 2024). In the US it holds FDA Breakthrough Device designation (Nov 2023), which is not clearance or authorization. CLAiR is not listed on the Toku homepage fetched on the verification date. · source
Last verified
2026-10-07

DotAEye is independent of Toku Eyes. Confirm indications, intended use, and clearance status with the manufacturer before clinical use.